| 381 |
|
Clinical Investigations - lnterventional Cardiology - Does stent design affect probability of restenosis? A randomized trial comparing Multilink stents with GFX stents/
|
Yoshitomi, Yuji
|
C. V. Mosby Co
|
2001
|
|
|
|
| 382 |
|
Clinical Investigations - lnterventional Cardiology - Feasibility of photopheresis to reduce the occurrence of restenosis after percutaneous transluminal coronary angioplasty: A clinical pilot study/
|
Bisaccia, Emil
|
C. V. Mosby Co
|
2001
|
|
|
|
| 383 |
|
Clinical Investigations - lnterventional Cardiology - Primary percutoneous coronary interventions in patients with acute myocardial infarction and prior coronary artery bypass grafting/
|
Suwaidi, Jossim AL
|
C. V. Mosby Co
|
2001
|
|
|
|
| 384 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - A Canadian comparison of data sources for coronary artery bypass surgery outcome "report cards"/
|
Ghali, William A
|
C. V. Mosby Co
|
2000
|
|
|
|
| 385 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Association of patients' perception of health status and exercise electrocardiogram, myocardial perfusion imaging, and ventricular function measures/
|
Mattera, Jennifer A
|
C. V. Mosby Co
|
2000
|
|
|
|
| 386 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Clinical outcome of a cohort of patients eligible for therapeutic angiogenesis or transmyocardial revascularization/
|
Mukherjee, Debabrata
|
C. V. Mosby Co
|
2001
|
|
|
|
| 387 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Comparative 30-day economic and clinical outcomes of platelet glycoprotein IIb/IIIa inhibitor use during elective percutaneous coronary intervention: Prairie ReoPro Versus Integrilin Cost Evaluation (PRICE) Trial - The PRICE Investigators, Springfield, Ill, Boston, Mass, and St Louis, Mo/
|
|
C. V. Mosby Co
|
2001
|
|
|
|
| 388 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Cost-effectiveness of b-blocker therapy with metoprolol or with carvedilol for treatment of heart failure in Canada/
|
Levy, Adrian R
|
C. V. Mosby Co
|
2001
|
|
|
|
| 389 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Economic assessment of rheolytic thrombectomy versus intracoronary urokinase for treatment of extensive intracoronary thrombus: Results from a randomized clinical trial/
|
Cohen, David J
|
C. V. Mosby Co
|
2001
|
|
|
|
| 390 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Epidemiologic study of use of resources in patients with unstable angina: The EARISA Registry/
|
Maggioni, Aldo Pietro
|
C. V. Mosby Co
|
2000
|
|
|
|
| 391 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Hematocrit and the risk of coronary heart disease mortality/
|
Brown, David W
|
C. V. Mosby Co
|
2001
|
|
|
|
| 392 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Impact of the Duett sealing device on quality of life and hospitalization costs for coronary diagnostic and interventional procedures: Results from the Study of Economic and Quality of Life substudy of the SEAL trial/
|
Zhang, Zefeng
|
C. V. Mosby Co
|
2001
|
|
|
|
| 393 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Predictors of medical events and of their competitive interactions in the Cardiac Insufficiency Bisoprolol Study 2 (CIBIS-2)/
|
Funck-Brentano, Christian
|
C. V. Mosby Co
|
2001
|
|
|
|
| 394 |
|
Clinical Investigations - Outcomes, Health Policy, and Managed Care - Variation in patient management and outcomes for acute coronary syndromes in Latin America and North America: Results from the Platelet IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) trial/
|
Cohen, Mauricio G
|
C. V. Mosby Co
|
2001
|
|
|
|
| 395 |
|
Clinical Investigations - Peripheral Vascular Disease - Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease/
|
Gianetti, Jacopo
|
C. V. Mosby Co
|
2001
|
|
|
|
| 396 |
|
Clinical Investigations - Secondary Prevention and Rehabilitation - Cost-effectiveness of provastatin therapy for survivors of myocardial infarction with average cholesterol levels/
|
Tsevat, Joel
|
C. V. Mosby Co
|
2001
|
|
|
|
| 397 |
|
Clinical Investigations - Secondary Prevention and Rehabilitation - Current perspectives on the management of hypertriglyceridemia/
|
Miller, Michael
|
C. V. Mosby Co
|
2000
|
|
|
|
| 398 |
|
Clinical Investigations - Secondary Prevention and Rehabilitation - Effectiveness of a planned strategy using cardiac rehabilitation nurses for the management of dyslipidemia in patients with coronary artery disease/
|
Senaratne, Manohara P J
|
C. V. Mosby Co
|
2001
|
|
|
|
| 399 |
|
Clinical Investigations - Secondary Prevention and Rehabilitation - Effect of atorvastatin on blood lipid levels in the first 2 weeks of treatment: A randomized, placebo-controlled study/
|
Schrott, Helmut G
|
C. V. Mosby Co
|
2000
|
|
|
|
| 400 |
|
Clinical Investigations - Secondary Prevention and Rehabilitation - Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe clyslipidernia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH)/
|
McPherson, Ruth
|
C. V. Mosby Co
|
2001
|
|
|
|
기사
(553)
